Navindra P Seeram Selected Research

Neoplasms (Cancer)

4/2024	Bipiperidinyl Derivatives of Cannabidiol Enhance Its Antiproliferative Effects in Melanoma Cells.
8/2023	Establishment of Human PD-1/PD-L1 Blockade Assay Based on Surface Plasmon Resonance (SPR) Biosensor.
1/2023	Chemical constituents of industrial hemp roots and their anti-inflammatory activities.
4/2021	Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review.
7/2015	Anti-Inflammatory Effects of Novel Standardized Solid Lipid Curcumin Formulations.
1/2013	Maple polyphenols, ginnalins A-C, induce S- and G2/M-cell cycle arrest in colon and breast cancer cells mediated by decreasing cyclins A and D1 levels.
5/2012	Cytotoxicity and structure activity relationship studies of maplexins A-I, gallotannins from red maple (Acer rubrum).
2/2012	Synthesis, characterization, and preliminary in vitro studies of vanadium(IV) complexes with a Schiff base and thiosemicarbazones as mixed-ligands.
4/2011	Chinese red yeast rice inhibition of prostate tumor growth in SCID mice.
5/2010	Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Navindra P Seeram Research Topics

Disease

30	Neoplasms (Cancer) 04/2024 - 01/2003
13	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 05/2004
12	Colonic Neoplasms (Colon Cancer) 10/2014 - 05/2003
11	Inflammation (Inflammations) 07/2023 - 08/2004
9	Alzheimer Disease (Alzheimer's Disease) 07/2023 - 06/2005
8	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2023 - 06/2016
8	Breast Neoplasms (Breast Cancer) 01/2015 - 02/2004
5	Neuroinflammatory Diseases 11/2023 - 11/2016
4	Melanoma (Melanoma, Malignant) 04/2024 - 09/2004
3	Parkinson Disease (Parkinson's Disease) 12/2020 - 08/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2019 - 11/2007
3	Carcinogenesis 01/2010 - 09/2004
2	Peritonitis 11/2023 - 07/2023
2	COVID-19 09/2022 - 10/2021
2	Diabetes Mellitus 06/2021 - 07/2015
2	Neuroblastoma 12/2020 - 08/2018
2	Obesity 04/2019 - 01/2019
2	Chronic Disease (Chronic Diseases) 02/2017 - 07/2015
2	Paralysis (Palsy) 11/2016 - 01/2016
2	Urinary Tract Infections (Urinary Tract Infection) 08/2015 - 09/2012
2	Arthritis (Polyarthritis) 09/2013 - 06/2012
2	Multiple Myeloma 07/2006 - 09/2004
1	Skin Neoplasms (Skin Cancer) 12/2023
1	Neuralgia (Stump Neuralgia) 11/2023
1	Necrosis 01/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2022
1	Cognitive Dysfunction 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 11/2023 - 02/2006
11	PolyphenolsIBA 10/2021 - 05/2004
10	EnzymesIBA 11/2022 - 01/2003
8	PhytochemicalsIBA 07/2023 - 08/2004
8	ellagitanninIBA 03/2019 - 09/2007
6	LipopolysaccharidesIBA 11/2023 - 11/2016
6	Neuroprotective AgentsIBA 12/2020 - 01/2014
6	Anthocyanins (Anthocyanin)IBA 06/2012 - 01/2003
6	AndrogensIBA 04/2011 - 08/2006
5	Amyloid (Amyloid Fibrils)IBA 09/2021 - 01/2014
5	Hydrolyzable TanninsIBA 05/2017 - 02/2006
4	AntioxidantsIBA 12/2023 - 11/2007
4	CytokinesIBA 07/2023 - 02/2008
4	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 12/2008
3	Adenosine Triphosphate (ATP)IBA 11/2023 - 05/2004
3	Advanced Glycation End ProductsIBA 08/2018 - 06/2016
3	punicalaginIBA 09/2013 - 06/2005
3	red yeast riceIBA 04/2011 - 07/2008
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2011 - 07/2008
3	Lovastatin (Mevacor)FDA LinkGeneric 04/2011 - 07/2008
2	CannabinoidsIBA 04/2024 - 01/2023
2	Monophenol Monooxygenase (Tyrosinase)IBA 12/2023 - 05/2017
2	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 11/2023 - 07/2023
2	CollagenIBA 11/2022 - 07/2020
2	Peptide Hydrolases (Proteases)FDA Link 09/2022 - 10/2021
2	Thrombin FDA Link 12/2020 - 01/2020
2	Peptides (Polypeptides)IBA 01/2020 - 02/2008
2	Amyloid beta-PeptidesIBA 01/2020 - 11/2016
2	Biomarkers (Surrogate Marker)IBA 03/2019 - 01/2015
2	ginnalin AIBA 01/2013 - 07/2012
2	Ellagic AcidIBA 01/2012 - 01/2010
2	ResveratrolIBA 08/2011 - 09/2004
2	3 beta-hydroxysteroid dehydrogenase type IIIBA 04/2011 - 12/2008
2	CholesterolIBA 04/2011 - 12/2005
2	Messenger RNA (mRNA)IBA 02/2010 - 08/2006
2	Aromatase (CYP19)IBA 01/2010 - 02/2009
2	Estrogens (Estrogen)FDA Link 01/2010 - 02/2009
2	AcidsIBA 01/2010 - 01/2006
2	Testosterone (Sustanon)FDA Link 01/2010 - 12/2008
2	CarcinogensIBA 02/2008 - 09/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2008 - 08/2006
2	Oxygen (Dioxygen)IBA 02/2008 - 06/2005
2	Prostate-Specific Antigen (Semenogelase)IBA 09/2007 - 08/2006
2	Sulindac (Copal)FDA LinkGeneric 12/2006 - 05/2003
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2006 - 01/2003
2	TeaIBA 07/2006 - 06/2005
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2003 - 01/2003
1	CannabidiolIBA 04/2024
1	pyrazoleIBA 12/2023
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 11/2023
1	Purinergic P2X ReceptorsIBA 11/2023
1	Ion Channels (Ion Channel)IBA 11/2023
1	LigandsIBA 08/2023
1	Programmed Cell Death 1 ReceptorIBA 08/2023
1	Immune Checkpoint InhibitorsIBA 08/2023
1	Interleukin-1beta (Interleukin 1 beta)IBA 07/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2023
1	Interleukin-6 (Interleukin 6)IBA 07/2023
1	InflammasomesIBA 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 11/2022
1	Collagen Type I (Type I Collagen)IBA 11/2022
1	KynurenineIBA 09/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	Betulinic AcidIBA 01/2022
1	keteneIBA 01/2022
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	GlucosidasesIBA 06/2021
1	LipidsIBA 06/2021

Therapy/Procedure

12	Therapeutics 11/2023 - 08/2004
4	Chemoprevention 12/2008 - 07/2006
2	Immunotherapy 08/2023 - 04/2021